LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

Home・Akcijų sąrašas・Medtronic PLC

Search

Medtronic PLC

Uždarymo kaina

SektoriusSveikatos priežiūra

78.45 1.54

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

76.73

Max

78.95

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-231M 1.1B
Pardavimai	57M 9B
P/E Sektoriaus vid.	21.598 51.415
Pelnas, tenkantis vienai akcijai	0.89
Dividendų pajamingumas	3.72
Pelno marža	12.675
Darbuotojai	95,000
EBITDA	124M 2.5B

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+38.58% upside

Dividendai
By Dow Jones
Dividendų pajamingumas Sektoriaus vid.	3.72% 2.34%
Kitas uždarbis	2026-06-03
Kitas dividendų mokėjimo data	2026-07-10
Kita Ex Dividend data	2026-06-26

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-28B 99B
Ankstesnė atidarymo kaina	76.91
Ankstesnė uždarymo kaina	78.45

Naujienos nuotaikos

By Acuity

35%

65%

103 / 345 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bearish Evidence

83.26 / 84.875 Palaikymas ir pasipriešinimas

Medtronic PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-10 11:19; UTC

Įsigijimai, susijungimai, perėmimai

Medtronic to Buy Scientia Vascular in $550 Million Deal

2026-02-17 12:43; UTC

Uždarbis

Medtronic 3Q Profit Falls Despite Higher Revenue

2026-02-03 13:53; UTC

Įsigijimai, susijungimai, perėmimai

Medtronic to Acquire CathWorks in Deal Valued Up to $585 Million

2026-04-22 11:27; UTC

Uždarbis

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

2026-04-20 11:50; UTC

Įsigijimai, susijungimai, perėmimai

Medtronic Completes Acquisition Of CathWorks, Expanding Its Leadership In Transforming Care For Patients With Cardiovascular Disease >MDT

2026-03-24 20:59; UTC

Uždarbis

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

2026-03-10 10:46; UTC

Įsigijimai, susijungimai, perėmimai

Medtronic: Scientia Deal Complements Neurovascular Portfolio >MDT

2026-03-10 10:46; UTC

Įsigijimai, susijungimai, perėmimai

Medtronic: Scientia Deal Includes Potential Undisclosed Earn-Out, Milestone Payments >MDT

2026-03-10 10:45; UTC

Įsigijimai, susijungimai, perėmimai

Medtronic: Scientia Vascular Acquisition Valued at $550 Million >MDT

2026-03-10 10:45; UTC

Įsigijimai, susijungimai, perėmimai

Medtronic to Acquire Scientia Vascular >MDT

2026-02-17 21:21; UTC

Uždarbis

These Stocks Are Today's Movers: Paramount, Masimo, Medtronic, Kyndryl, eToro, Genuine Parts, Southwest, and More -- Barrons.com

2026-02-17 18:11; UTC

Uždarbis

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

2026-02-17 14:48; UTC

Uždarbis

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

2026-02-17 13:00; UTC

Uždarbis

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

2026-02-17 12:05; UTC

Uždarbis

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

2026-02-17 11:47; UTC

Uždarbis

Medtronic Sees 2026 EPS up 4.5%, Excluding Potential Impact From Tariffs >MDT

2026-02-17 11:47; UTC

Uždarbis

Medtronic Still Sees FY26 Organic Revenue Up About 5.5% >MDT

2026-02-17 11:46; UTC

Uždarbis

Medtronic FY26 View Includes Potential Impact From Tariffs of About $185M >MDT

2026-02-17 11:46; UTC

Uždarbis

Medtronic Backs FY26 View of Adj EPS $5.62-Adj EPS $5.66 >MDT

2026-02-17 11:46; UTC

Uždarbis

Medtronic Reiterates FY26 Organic Rev Growth, EPS Guidance >MDT

2026-02-17 11:45; UTC

Uždarbis

Medtronic 3Q Adj EPS $1.36 >MDT

2026-02-17 11:45; UTC

Uždarbis

Medtronic 3Q Neuroscience Portfolio Rev $2.56B >MDT

2026-02-17 11:45; UTC

Uždarbis

Medtronic 3Q Organic Revenue Up 6.0% >MDT

2026-02-17 11:45; UTC

Uždarbis

Medtronic 3Q Sales $9.02B >MDT

2026-02-17 11:45; UTC

Uždarbis

Medtronic 3Q Diabetes Rev $796M >MDT

2026-02-17 11:45; UTC

Uždarbis

Medtronic 3Q Cardiovascular Portfolio Rev $3.46B >MDT

2026-02-17 11:45; UTC

Uždarbis

Medtronic 3Q Medical Surgical Portfolio Rev $2.17B >MDT

2026-02-17 11:45; UTC

Uždarbis

Medtronic 3Q Net $1.14B >MDT

2026-02-17 11:45; UTC

Uždarbis

Medtronic 3Q EPS 89c >MDT

2026-02-17 09:53; UTC

Karštos akcijos

Stocks to Watch Tuesday: Norwegian, Hyatt, Zim, Medtronic -- WSJ

Akcijų palyginimas

Kainos pokytis

Medtronic PLC Prognozė

Kainos tikslas

By TipRanks

38.58% į viršų

12 mėnesių prognozė

Vidutinis 105.53 USD 38.58%

Aukščiausias 120 USD

Žemiausias 86 USD

Remiantis 17 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Medtronic PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

17 ratings

11

Pirkti

6

Laikyti

0

Parduoti

Remiantis 17 analitikų, pateikusių Medtronic PLC akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

83.26 / 84.875Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

All events are bullish.

All events are bearish.

Rinkos nuotaikos

By Acuity

103 / 345 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Kitos sektoriaus akcijos

LLY

Eli Lilly and Co.

1,018.6

JNJ

Johnson and Johnson

229.93

ABBV

AbbVie Inc

213.62

UNH

UnitedHealth Group Inc

389.29

AZN

AstraZeneca PLC

184.71

Live chat